Senior Regulatory Affairs Consultant

Senior Regulatory Affairs Consultant

My client is a pre-clinical stage start-up company focused on developing gene editing technologies for the treatment of Duchene muscular dystrophy and other neuromuscular diseases. They are looking for a Senior Regulatory Affairs Consultant to lead regulatory activities for the company’s programs in development.  Responsibilities will include the support of Pre-ID meetings, development of regulatory strategies, and execution of eventual filings. This is a remote based position.

Responsibilities:

  • Management of all regulatory aspects of the company’s development activities in support of Pre-IND meetings
  • Be the key contributor in the design of regulatory strategies and execution of eventual FDA filings
  • Contribute to company initiatives related to regulatory affairs operations and strategy
  • Work with the project team to identify and develop an optimum regulatory strategy for Pre-IND and IND activities
  • Independently interact with regulatory authorities, consultant peers on a daily basis
  • Write, review and edit regulatory documents

 

Knowledge and Skills:

  • Minimum PhD or equivalent in immunology or a related discipline required
  • Minimum 10+ years in Regulatory Affairs with experience in early through mid-stage development a must
  • Experience with US and international management of Pre IND/IND filing activities
  • Experience developing and leading regulatory strategies for clinical and pre-clinical programs
  • Experience in genetic mutations resulting in neuromuscular/neurodegenerative diseases desirable but not required
  • Experience working within pediatric orphan drug indications and solid understanding of regulatory requirements for and experience with submission of applications (IND) in eCTD format

 

Number of hours worked per week: 20-30 hours a week

Length of Assignment: 6 months

Position Location: Remote

Apply for this Position

    Your Name*

    Your Email*

    Resume

    Your Message

    This entry was posted in . Bookmark the permalink.